BMY sees reason for optimism over the final half of the year.
Wendy's, Regeneron and Teladoc -- why would you unload them now?
The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.
Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.
There is no thought of selling here and now, even with politicized pressure on the industry.
Biotechnology is always high risk but the right plays move unlike anything else.
My focus is the implied volatility. It gives us put selling or ratio put selling for credit opportunity.
And there is a particular Brazilian ETF that is worth exploring if you want to take advantage of rising commodity prices and the falling U.S. dollar.
Be cautious about ALXN in the short-run.
The charts are looking soft right now.